Research engineer in Immunomonitoring and Immunotherapy development
This is a limited term appointment with funding for this post expected to be available for a period of 15 months from February 2022 in the first instance with the possibility of extension. The candidate will be under the supervision of Dr. Else Marit Inderberg (group leader).
Job description/Project description
The work entails culturing processing patient samples, isolating T cells, performing immunological assays including flow cytometry and mass cytometry, cytokine measurements, proliferation assays.
Furthermore, the candidate will contribute in pre-clinical projects by optimising T cell culture and engineering with immune receptors such as T cell receptors (TCR) and chimeric antigen receptors (CAR) as well as setting up potency assays to measure the efficacy of novel therapies.
More information can be found here